Remimazolam for the prevention of emergence agitation in adults following nasal surgery under general anesthesia: a prospective randomized clinical controlled trial

Abstract Background Remimazolam is a novel intravenous sedative/anesthetic drug that belongs to the ultra-short-acting class of benzodiazepines. The purpose of this study was to evaluate the effectiveness of postoperative use of remimazolam in preventing emergence agitation (EA) in adults following...

Full description

Bibliographic Details

Published in:	BMC Anesthesiology
Main Authors:	Yanfei Lu, Qiaomin Xu, Hong Dai, Jimin Wu, Mengting Ai, Haiyan Lan, Xiaoli Dong, Gongchen Duan
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Subjects:	Remimazolam Nasal surgery Emergence agitation General anesthesia
Online Access:	https://doi.org/10.1186/s12871-024-02875-1